Teva Pharmaceuticals recalls 9mg Budesonide Extended-Release Tablets due to failed dissolution specifications. This may affect medication effectiveness. Contact for return instructions.
Failed Dissolution Specifications
Teva is recalling 9mg Budes: Budesonide Extended-Release Tablets that failed dissolution tests. This could mean the medication isn't working properly for users.
The tablets didn't dissolve correctly as intended. This could lead to inconsistent medication levels in the body, potentially reducing effectiveness.
People prescribed this medication by a doctor. Those with asthma or other conditions requiring this drug are most at risk.
Check for the 9mg Budesonide Extended-Release Tablets, 30-count bottle, Rx Only. Look for NDC 0591-2510-30 and lot number 100047273.
Identify the product by checking the NDC code 0591-2510-30 and lot number 100047273.
The recall is due to failed dissolution specifications, which may affect medication effectiveness. Consult your doctor for advice.
Check for the 9mg Budesonide Extended-Release Tablets, 30-count bottle, Rx Only with NDC 0591-2510-30 and lot number 100047273.
The recall does not specify a remedy. Contact Teva Pharmaceuticals for further instructions.
We’ve drafted a message you can send Teva to request your refund or repair — edit it as you like.
Subject: Recall D-0275-2024 — Teva Teva Hello, I own a Teva that is covered by recall D-0275-2024 from Teva. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
